Submission Details

Molecule(s):
CC(C)(C)C(=O)C(C#N)C(=O)Nc1ccc(Cl)cc1

JOH-UNI-c7afdb96-1

CC(C)(C)C(=O)C(C#N)C(=O)Nc1ccc(Cl)cc1

N#C/C(C(=O)Nc1ccc(F)cc1)=C(/O)c1ccc(Cl)cc1

JOH-UNI-c7afdb96-2

N#C/C(C(=O)Nc1ccc(F)cc1)=C(/O)c1ccc(Cl)cc1

N#CC(C(=O)Nc1ccccc1)C(=O)c1cccs1

JOH-UNI-c7afdb96-3

N#CC(C(=O)Nc1ccccc1)C(=O)c1cccs1

N#CC(C(=O)Nc1ccccc1)C(=O)c1cccc(Cl)c1

JOH-UNI-c7afdb96-4

N#CC(C(=O)Nc1ccccc1)C(=O)c1cccc(Cl)c1

N#CC(C(=O)Nc1cccc(Cl)c1)C(=O)c1cccs1

JOH-UNI-c7afdb96-5

N#CC(C(=O)Nc1cccc(Cl)c1)C(=O)c1cccs1

Cc1cccc(NC(=O)C(C#N)C(=O)C2CCCC2)c1

JOH-UNI-c7afdb96-6

Cc1cccc(NC(=O)C(C#N)C(=O)C2CCCC2)c1

Cc1cccc(NC(=O)C(C#N)C(=O)C2CCC2)c1

JOH-UNI-c7afdb96-7

Cc1cccc(NC(=O)C(C#N)C(=O)C2CCC2)c1

Cc1cccc(NC(=O)C(C#N)C(=O)C2CC2)c1

JOH-UNI-c7afdb96-8

Cc1cccc(NC(=O)C(C#N)C(=O)C2CC2)c1

CCCSCC(=O)C(C#N)C(=O)Nc1ccccc1F

JOH-UNI-c7afdb96-9

CCCSCC(=O)C(C#N)C(=O)Nc1ccccc1F

CCCSCC(=O)C(C#N)C(=O)Nc1ccc(F)cc1F

JOH-UNI-c7afdb96-10

CCCSCC(=O)C(C#N)C(=O)Nc1ccc(F)cc1F

Cc1ccc(NC(=O)C(C#N)C(=O)CC(C)C)cc1

JOH-UNI-c7afdb96-11

Cc1ccc(NC(=O)C(C#N)C(=O)CC(C)C)cc1

CC(C)(C)CC(=O)C(C#N)C(=O)Nc1ccccc1

JOH-UNI-c7afdb96-12

CC(C)(C)CC(=O)C(C#N)C(=O)Nc1ccccc1

Cc1cccc(NC(=O)C(C#N)C(=O)CC(C)C)c1

JOH-UNI-c7afdb96-13

Cc1cccc(NC(=O)C(C#N)C(=O)CC(C)C)c1

CCC(CC)C(=O)C(C#N)C(=O)Nc1ccc(F)cc1

JOH-UNI-c7afdb96-14

CCC(CC)C(=O)C(C#N)C(=O)Nc1ccc(F)cc1

N#C/C(C(=O)NCc1ccccc1)=C(/O)CCl

JOH-UNI-c7afdb96-15

N#C/C(C(=O)NCc1ccccc1)=C(/O)CCl

C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1

JOH-UNI-c7afdb96-16

C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1

C/C(O)=C(\C#N)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1

JOH-UNI-c7afdb96-17

C/C(O)=C(\C#N)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1

Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1

JOH-UNI-c7afdb96-18

Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1


Design Rationale:

Related to Leflunomide and analogues as per a previous mail. SF5 analogue is made in our lab as part of a PhD programme so I can source this. (sorry, couldn't access the fragments so picked one at random below!)

Other Notes:

Available and would possibly be free from eMolecules.

Inspired By:
Discussion: